opioid sparing onco-anesthesia for paediatric patients.

Opioid sparing effects of ketamine based total intravenous anesthesia for minor procedures in pediatric oncoanesthesia: comparison between different additives

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202008462414719

Enrollment

Registered

2020-08-13

Start date

2020-08-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Paediatrics Anaesthesia

Interventions

ketamine

propofol

dexmedetomidine

magnesium sulphate

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: eighty eight child aged 2-10 years, ASA physical status I and II, scheduled for brief intervention related to cancer (e.g. intrathecal delivery of chemotherapy, bone marrow aspiration)

Exclusion criteria

Exclusion criteria: parents' refusal, procedures > 30 min, complicated interventions, impaired renal or hepatic function, allergy or contraindication to any of studied drugs

Design outcomes

Primary

Measure	Time frame
total fentanyl consumption	—

Secondary

Measure	Time frame
Hemodynamic parameters (HR and MAP) ; Frequency of movement;Recovery time ;Pain score; Length of PACU stay;Any adverse effects e.g. PONV, postoperative agitation	—

Countries

Egypt

Contacts

Public ContactMona Elghamry

lecturer

drmonagh19802000@gmail.com+201060101867

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026